|
|
 |
Smarter Treatment With Stewardship
ISSUE: DECEMBER, 2009
The concept of antimicrobial stewardship is gaining ground in the fight against resistant pathogens. According to the World Health Organization, hospital-acquired infections are on the rise—resulting in increased economic burden, additional strain on hospital staff and laboratory personnel, increased use of antibiotics, and higher mortality rates.
read more |
New Study Shines Light On Vancomycin Toxicity
More vigilance on trough levels by specialty urged
ISSUE: DECEMBER, 2009
Vancomycin trough levels greater than 15 mg/L may cause nephrotoxicity and should be closely monitored, especially in patients at risk for renal problems, according to new research from the University of California, Davis.
read more |
E. coli–Free, But on Who’s Dime?
ISSUE: DECEMBER, 2009
After a nearly decade-long delay, the US Department of Agriculture’s Animal and Plant Health Inspection Service (APHIS) granted conditional license for a bovine Escherichia coli vaccine in March of this year. The conditional license allows Epitopix to manufacture the vaccine for the beef industry while conducting additional efficacy studies.
read more |
Moving Fluoroquinolones to the Front Of the Line
ISSUE: DECEMBER, 2009
Fluoroquinolones are potent, broad-spectrum antibiotics that are widely used to treat gram- positive and gram-negative bacterial infections. Increasingly, they are being used for treatment of Mycobacterium tuberculosis, generally as second-line agents against multidrug-resistant (MDR) organisms.
read more |
|
|
|
|
|
|
|
|
|
VOLUME 12:09 • 2009 |
|
|
| |
|
